Rupleen Kaur


MD/PhD Student | Case Western Reserve University

CMT AND NEUROGENIC DISEASE P.337Giant axonal neuropathy presenting as CMT2: results from the NIH natural history study


Journal article


D. Saade, D. Bharucha-Goebel, G. Norato, A. Foley, M. Waite, M. Jain, S. Debs, R. Vasavada, C. Nichols, R. Kaur, S. Donkervoort, S. Neuhaus, Y. Hu, T. Lehky, S. Gray, M. Fink
Neuromuscular Disorders, 2018

Semantic Scholar DOI
Cite

Cite

APA
Saade, D., Bharucha-Goebel, D., Norato, G., Foley, A., Waite, M., Jain, M., … Fink, M. (2018). CMT AND NEUROGENIC DISEASE P.337Giant axonal neuropathy presenting as CMT2: results from the NIH natural history study. Neuromuscular Disorders.

Chicago/Turabian
Saade, D., D. Bharucha-Goebel, G. Norato, A. Foley, M. Waite, M. Jain, S. Debs, et al. “CMT AND NEUROGENIC DISEASE P.337Giant Axonal Neuropathy Presenting as CMT2: Results from the NIH Natural History Study.” Neuromuscular Disorders (2018).

MLA
Saade, D., et al. “CMT AND NEUROGENIC DISEASE P.337Giant Axonal Neuropathy Presenting as CMT2: Results from the NIH Natural History Study.” Neuromuscular Disorders, 2018.


Share